Patients perspective

In 2017 we celebrated our 25th anniversary as a society. To illustrate the progress that gene and cell therapy has made since ESGCT was founded in 1992, we made made an overview of patients who have been treated with these therapies and the effect this had on their lives.

Patient perspective

In 2017 we celebrated our 25th anniversary as a society. To illustrate the progress that gene and cell therapy has made since ESGCT was founded in 1992, we made made an overview of patients who have been treated with these therapies and the effect this had on their lives.




Our members and others all over the world work hard everyday to change many more lives over the next 25 years and beyond. Many disorders for which gene therapies are being developed have patient organisations. Patient organisations are often involved in patient advocacy and providing information and peer support. They may also be involved in research or fundraising for research. Most patient organisations can be easily found through their websites and social media presence and some can be found on our Gene and Cell Therapy Community Heatmap.